本页面由Tiger Trade Technology Pte. Ltd.提供服务

Estrella Immunopharma

0.3379
-0.0721-17.59%
成交量:67.80万
成交额:22.35万
市值:1,469.79万
市盈率:-1.35
高:0.3630
开:0.3250
低:0.3200
收:0.4100
52周最高:3.15
52周最低:0.3083
股本:4,349.79万
流通股本:3,821.41万
量比:0.32
换手率:1.77%
股息:- -
股息率:- -
每股收益(TTM):-0.2502
每股收益(LYR):-0.3548
净资产收益率:-268.50%
总资产收益率:-251.86%
市净率:-1.98
市盈率(LYR):-0.95

数据加载中...

2026/09/08

重要事件披露

Form 8-K - Current report
2026/08/21

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/06/30

重要事件披露

Form 8-K - Current report
2026/05/16

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/30

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2026/03/18

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/23

SEC问询函

Form CORRESP - Correspondence
2026/01/22

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/16

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/13

重要事件披露

Form 8-K - Current report
2026/01/07

重要事件披露

Form 8-K - Current report
2025/12/22

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/12/04

重要事件披露

Form 8-K - Current report
2025/11/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/06

重要事件披露

Form 8-K - Current report
2025/09/29

重要事件披露

Form 8-K - Current report
2025/09/26

重要事件披露

Form 8-K - Current report